Browsing Harvard Law School by Title
Now showing items 1563-1582 of 2408
-
Panel Discussion: Welfare Rights
(1979) -
The Paper of Record Meets an Ephemeral Web: An Examination of Linkrot and Content Drift within The New York Times
(Harvard Innovation Lab, Harvard Law School, 2021-04-26)Hyperlinks are a powerful tool for journalists and their readers. Diving deep into the context of an article is just a click away. But hyperlinks are a double-edged sword; for all of the internet’s boundlessness, what’s ... -
The Parliament of the Experts
(Duke University School of Law, 2009)In the administrative state, how should expert opinions be aggregated and used? If a panel of experts is unanimous on a question of fact, causation, or prediction, can an administrative agency rationally disagree, and on ... -
Partner Schmartner! EEOC v. Sidley Austin Brown & Wood
(Harvard Law School, 2007) -
Partyism
(2015)“Partyism” is a form of hostility and prejudice that operates across political lines. For example, some Republicans have an immediate aversive reaction to Democrats, and some Democrats have the same aversive reaction to ... -
Past, Present and Future in the Search for the Perfect Anti-epileptic Drug
(2002)This paper explores the development of anti-epileptic drugs, starting with the earliest forms of treatment, moving to the drugs currently in use and those recently approved by the FDA, and ending with the drugs (and devices!) ... -
The Past, Present, and Future of Direct-to-Consumer Genetic Testing: What we have Learned and Why Increased Regulation is Warranted
(2011)Almost a decade after the complete sequencing of the human genome, we have seen a proliferation of genetic testing services marketed directly to the consumer and purporting to use genetic information to generate individualized ... -
Patent Law, Antitrust Enforcement, and Public Access to Pharmaceuticals and Medical Technologies
(2003)Patent and antitrust laws impact public access to pharmaceuticals and medical technologies. Two instances—one involving Roche’s new class of HIV/AIDS drugs, the other an antitrust ... -
The Patent-Antitrust Intersection: A Reappraisal
(Harvard University, 1984)The conflict between antitrust law and patent policy has incessantly perplexed courts and commentators. In this Article, Professor Kaplow develops and analyzes a conceptual solution to the patent-antitrust puzzle. This ... -
Patents – the Starting Gun in the Race for the Human Genome
(2005)The race to sequence the human genome between the federal government’s Human Genome Project and the private firm Celera Genomics is one of the most fascinating tales in the history of science. This paper explores the role ... -
Paternalism, Hostility, and Concern for the Slippery Slope: Factors in Judicial Decision-Making When Religion and Regulation Collide
(1997)This paper will examine religious claims as they pertain to food and drug law issues, as exemplified by litigation surrounding 1) the Church of Scientology's use of an instrument known as the Hubbard Electrometer, and 2) ... -
Pauli Murray: Eleanor Roosevelt's Beloved Radical
(2016-02-29)During her long and contentious life that spanned much of the twentieth century, Pauli Murray (1910–1985) involved herself in nearly every progressive cause she could find. Yet the contributions of this black woman writer, ... -
Pay without Performance: Overview of the Issues
(University of Iowa, College of Law, 2005)In our recent book, Pay without Performance, and in several accompanying and subsequent papers, we seek to provide a full account of how managerial power and influence have shaped executive compensation in publicly traded ... -
Paying for Long-Term Performance
(University of Pennsylvania, 2010)Firms, investors, and regulators around the world are now seeking to ensure that the compensation of public company executives is tied to long-term results, in part to avoid incentives for excessive risk taking. This Article ... -
PBM and Pharmaceutical Company Mergers: Policy and Regulatory Implications
(1994)A recent trend in the pharmaceutical industry has been for large pharmaceutical companies to acquire or merge with PBMs (prescriptionlpharmacy-benefits-management companies). Merck started this trend in November 1993 by ... -
Peer Production of Survivable Critical Infrastructures
(Cambridge University Press, 2005) -
Peer Production, the Commons, and the Future of the Firm
(2017)From free and open source software, through Wikipedia to video journalism, peer production plays a more significant role in the information production environment than was theoretically admissible by any economic model of ...